OSUR Return on Tangible Equity | ORASURE TECHNOLOGIES, INC

ORASURE TECHNOLOGIES, INC (OSUR) Return on Tangible Equity

2026-06-30: Return Tang Equity -17.99%.
2026-03-31: Return Tang Equity -27.99%.
2025-12-31: Return Tang Equity -23.27%.
2025-09-30: Return Tang Equity -19.85%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-17.99%
2026-03-31	-27.99%
2025-12-31	-23.27%
2025-09-30	-19.85%
2025-06-30	-15.86%
2025-03-31	-9.44%
2024-12-31	-5.28%
2024-09-30	2.92%
2024-06-30	6.93%
2024-03-31	5.86%
2023-12-31	13.63%
2023-09-30	13.49%
2023-06-30	12.60%
2023-03-31	8.63%
2022-12-31	9.45%
2022-09-30	1.29%
2022-06-30	-5.68%
2022-03-31	0.14%
2021-12-31	-7.06%
2021-09-30	-3.23%
2021-06-30	1.53%
2021-03-31	-1.10%
2020-12-31	-4.38%
2020-09-30	-4.34%
2020-06-30	-0.70%
2020-03-31	5.25%
2019-12-31	6.50%
2019-09-30	9.40%
2019-06-30	7.93%
2019-03-31	8.07%
2018-12-31	7.85%
2018-09-30	6.93%
2018-06-30	6.30%
2018-03-31	7.07%
2017-12-31	13.47%
2017-09-30	13.99%
2017-06-30	15.61%
2017-03-31	16.50%
2016-12-31	12.58%
2016-09-30	11.85%
2016-06-30	9.05%
2016-03-31	8.02%
2015-12-31	6.35%
2015-09-30	0.64%
2015-06-30	0.41%
2015-03-31	0.83%
2014-12-31	-3.37%
2014-09-30	3.07%
2014-06-30	0.89%
2014-03-31	-5.00%
2013-12-31	-8.15%
2013-09-30	-17.85%
2013-06-30	-18.24%
2013-03-31	-16.35%
2012-12-31	-10.43%
2012-09-30	-6.13%
2012-06-30	-14.35%
2012-03-31	-12.66%
2011-12-31	-11.71%
2011-09-30	-14.25%
2011-06-30	-5.72%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-23.27%
2024-12-31	-5.28%
2023-12-31	13.63%
2022-12-31	-5.39%
2021-12-31	-7.06%
2020-12-31	-4.38%
2019-12-31	6.50%
2018-12-31	7.85%
2017-12-31	13.47%
2016-12-31	12.58%
2015-12-31	6.35%
2014-12-31	-3.37%
2013-12-31	-8.15%
2012-12-31	-10.43%
2011-12-31	-11.71%
2010-12-31	-3.40%
2009-12-31	-7.53%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Anika Therapeutics, Inc. (ANIK)	United States	$0.272B	-51.71
Cytosorbents Corp (CTSO)	United States	$0.274B	-1.29
TriSalus Life Sciences, Inc. (TLSI)	United States	$0.283B	-9.92
InfuSystem Holdings, Inc (INFU)	United States	$0.253B	22.52
Mobia Medical, Inc. (MOBI)	United States	$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)	United States	$0.297B	-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)	United States	$0.238B	20.93
PRO DEX INC (PDEX)	United States	$0.234B	13.64
Embecta Corp. (EMBC)	United States	$0.319B	2.10
Neuronetics, Inc. (STIM)	United States	$0.216B	-3.25